Rosen, leading investor counsel, encourages lifecore biomedical, inc. investors to secure counsel before important deadline in securities class action – lfcr

New york, aug. 02, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of lifecore biomedical, inc. (nasdaq: lfcr) between october 7, 2020 and march 19, 2024. lifecore describes itself as an “integrated contract development and manufacturing organization in the u.s. and internationally.” a class action lawsuit has already been filed. if you wish to serve as lead plaintiff, you must move the court no later than september 27, 2024.
LFCR Ratings Summary
LFCR Quant Ranking